Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Westermann
A M
AM
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001862:Bone Resorption; D001943:Breast Neoplasms / Q000473:pathology*; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*
D004164:Diphosphonates; D010919:Placebos; D000077557:Ibandronic Acid